Saturday, 19 October 2019

Dr Ajit Singh joins Ibex Medical Analytics' advisory board

07 August 2019 | News

Dr. Singh's extensive experience in medical technologies will help grow the company's AI-based solutions footprint in pathology labs

Ibex Medical Analytics, the pioneer in artificial intelligence (AI)-based cancer diagnostics, announces that Dr. Ajit Singh, managing director of Artiman Ventures, a Silicon Valley based VC firm, is joining its advisory board.

Dr. Singh brings over 30 years of academic, medical and business experience to Ibex. Prior to Artiman, he has served as the global President and CEO of Siemens Oncology and Siemens Imaging Systems. Subsequently, he was the CEO of BioImagene, a digital-pathology based cancer diagnostics startup acquired by Roche. Dr. Singh also serves as adjunct professor at the Stanford University School of Medicine, and a member of the Board of Trustees at the American Association for Cancer Research (AACR) Foundation. Additionally, he is a senior advisor to the Tata Trusts Cancer Care Initiative.

Dr. Singh is a published author and holds a PhD. in Computer Science from Columbia University, specializing in Artificial Intelligence, as well as a master's in Computer Engineering from Syracuse University and a bachelor's in Electrical Engineering from Banaras Hindu University.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account